fr 139317 has been researched along with transforming growth factor beta in 1 studies
| Studies (fr 139317) | Trials (fr 139317) | Recent Studies (post-2010) (fr 139317) | Studies (transforming growth factor beta) | Trials (transforming growth factor beta) | Recent Studies (post-2010) (transforming growth factor beta) |
|---|---|---|---|---|---|
| 219 | 0 | 8 | 49119 | 560 | 17610 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ebihara, I; Fukui, M; Koide, H; Nakamura, T; Tomino, Y | 1 |
1 other study(ies) available for fr 139317 and transforming growth factor beta
| Article | Year |
|---|---|
Effect of a specific endothelin receptor A antagonist on mRNA levels for extracellular matrix components and growth factors in diabetic glomeruli.
Topics: Aging; Animals; Azepines; Blood Pressure; Collagen; Creatinine; Diabetes Mellitus, Experimental; Endothelin Receptor Antagonists; Extracellular Matrix Proteins; Fibroblast Growth Factor 2; Gene Expression; Growth Substances; Indoles; Kidney Glomerulus; Laminin; Male; Platelet-Derived Growth Factor; Proteinuria; Rats; Rats, Sprague-Dawley; Reference Values; RNA, Messenger; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 1995 |